166 related articles for article (PubMed ID: 11943609)
1. Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs).
Brockstedt U; Krajinovic M; Richer C; Mathonnet G; Sinnett D; Pfau W; Labuda D
Mutat Res; 2002 Apr; 516(1-2):41-7. PubMed ID: 11943609
[TBL] [Abstract][Full Text] [Related]
2. Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases.
Ozawa S; Schoket B; McDaniel LP; Tang YM; Ambrosone CB; Kostic S; Vincze I; Kadlubar FF
Carcinogenesis; 1999 Jun; 20(6):991-5. PubMed ID: 10357778
[TBL] [Abstract][Full Text] [Related]
3. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
Yang M; Choi Y; Hwangbo B; Lee JS
Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
[TBL] [Abstract][Full Text] [Related]
5. Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke.
Georgiadis P; Demopoulos NA; Topinka J; Stephanou G; Stoikidou M; Bekyrou M; Katsouyianni K; Sram R; Autrup H; Kyrtopoulos SA
Toxicol Lett; 2004 Apr; 149(1-3):269-80. PubMed ID: 15093273
[TBL] [Abstract][Full Text] [Related]
6. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism.
Rojas M; Cascorbi I; Alexandrov K; Kriek E; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Carcinogenesis; 2000 Jan; 21(1):35-41. PubMed ID: 10607731
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells.
Butkiewicz D; Grzybowska E; Phillips DH; Hemminki K; Chorazy M
Environ Mol Mutagen; 2000; 35(2):99-105. PubMed ID: 10712743
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.
Wan J; Shi J; Hui L; Wu D; Jin X; Zhao N; Huang W; Xia Z; Hu G
Environ Health Perspect; 2002 Dec; 110(12):1213-8. PubMed ID: 12460800
[TBL] [Abstract][Full Text] [Related]
9. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
10. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
[TBL] [Abstract][Full Text] [Related]
11. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure.
Schoket B; Papp G; Lévay K; Mracková G; Kadlubar FF; Vincze I
Mutat Res; 2001 Oct; 482(1-2):57-69. PubMed ID: 11535249
[TBL] [Abstract][Full Text] [Related]
12. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms.
Butkiewicz D; Grzybowska E; Hemminki K; Ovrebø S; Haugen A; Motykiewicz G; Chorazy M
Mutat Res; 1998 Jul; 415(1-2):97-108. PubMed ID: 9711266
[TBL] [Abstract][Full Text] [Related]
13. An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors.
Schwartzbaum JA; Ahlbom A; Lönn S; Warholm M; Rannug A; Auvinen A; Christensen HC; Henriksson R; Johansen C; Lindholm C; Malmer B; Salminen T; Schoemaker MJ; Swerdlow AJ; Feychting M
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):559-65. PubMed ID: 17372252
[TBL] [Abstract][Full Text] [Related]
14. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
[TBL] [Abstract][Full Text] [Related]
15. The effect of the genetic polymorphisms of CYP1A1,CYP2D6, GSTM1 and GSTP1 on aromatic DNA adduct levels in the population of healthy women.
Grzybowska E; Butkiewicz D; Motykiewicz G; Chorazy M
Mutat Res; 2000 Sep; 469(2):271-7. PubMed ID: 10984688
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer.
Dialyna IA; Arvanitis DA; Spandidos DA
Int J Mol Med; 2001 Jul; 8(1):79-87. PubMed ID: 11408954
[TBL] [Abstract][Full Text] [Related]
17. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population.
Hlavata I; Vrana D; Smerhovsky Z; Pardini B; Naccarati A; Vodicka P; Novotny J; Mohelnikova-Duchonova B; Soucek P
Oncol Rep; 2010 Nov; 24(5):1347-53. PubMed ID: 20878130
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer: role of polymorphisms in biotransformation enzymes.
Sarmanová J; Sůsová S; Gut I; Mrhalová M; Kodet R; Adámek J; Roth Z; Soucek P
Eur J Hum Genet; 2004 Oct; 12(10):848-54. PubMed ID: 15280903
[TBL] [Abstract][Full Text] [Related]
19. Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms.
Whyatt RM; Perera FP; Jedrychowski W; Santella RM; Garte S; Bell DA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):207-12. PubMed ID: 10698483
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
